Beaumont Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,500
Closed -$7.1K 43
2026
Q1
$7.1K Buy
+15,500
New +$14.3K 0.01% 31
2024
Q4
Sell
-10,000
Closed -$25.3K 58
2024
Q3
$25.3K Buy
+10,000
New +$32.6K 0.02% 49

Other funds holding GUTS

Beaumont Capital Management's GUTS Position: Q2 2026 in Review

Beaumont Capital Management sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 15,500 shares — an estimated $7.1K sold.

Beaumont Capital Management first reported a position in GUTS in Q3 2024 and held it in 2 quarters. The position peaked at $25.3K in Q3 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Beaumont Capital Management reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
  • Beaumont Capital Management sold 15,500 Fractyl Health shares in Q2 2026, an estimated $7.1K.
  • Beaumont Capital Management first reported a position in Fractyl Health in Q3 2024 and held it in 2 quarters.
  • Beaumont Capital Management's Fractyl Health position peaked at $25.3K in Q3 2024.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Beaumont Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.